NMPA-2021-0024-V424

Type II variation for application NMPA-2021-0024. Type II variation: New Dosage Strength for Neprilozone — critical change

Variation Number
NMPA-2021-0024-V424
Type
Type II
Application
NMPA-2021-0024
Change
CHG-2021-0124
Status
Active
Fee
€59,671
Submitted
2023-05-20
Approved
—
Description

Type II variation: New Dosage Strength for Neprilozone — critical change